CASZ1
protein-codingcastor zinc finger 1, the group of Zinc fingers C2H2-type
Gene summary
The protein encoded by this gene is a zinc finger transcription factor. The encoded protein may function as a tumor suppressor, and single nucleotide polymorphisms in this gene are associated with blood pressure variation. Alternative splicing results in multiple transcript variants that encode different protein isoforms. [provided by RefSeq, Jul 2012]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~160.0 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0005453
Submitter: ClinGen
**CASZ1** was first reported in relation to autosomal dominant congenital heart disease in 2016 (Huang et al., PMID: 27693370). 2 variants (missense) that have been reported in 5 probands in 2 publications (PMIDs: 27693370, 28641477) are included in this curation. The mechanism of pathogenicity appears to be loss-of-function. This gene-disease relationship is also supported by experimental evidence (mouse model, expression-level evidence) (PMID: 25190801, NCBI Fetal Expression Data). Homozygous mutant mice show structural congenital heart anomalies. In summary, there is limited evidence to support this gene-disease relationship. Although more evidence is needed to support a causal role, no convincing evidence has emerged that contradicts the gene-disease relationship. This classification was approved by the ClinGen Congenital Heart Disease GCEP on the meeting date 8/12/2024 (SOP Version 10).
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to CASZ1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001079843.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 6 | 191 | 14 | 211 | ||
| missense | 1 | 338 | 76 | 7 | 422 | |
| nonsense | 1 | 6 | 5 | 12 | ||
| start loss | 0 | |||||
| frameshift | 3 | 2 | 8 | 13 | ||
| splice donor/acceptor (+/-2bp) | 3 | 4 | 7 | |||
| Total | 5 | 11 | 361 | 267 | 21 | 665 |
Highest pathogenic variant AF is 0.000008893657
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001073312.1 | 18 | MANE Select | |
| Ensembl | ENSP00000366221.3 | 18 | MANE Select | |
| RefSeq | NP_060236.3 | 13 | Standard | |
| Ensembl | ENSP00000339445.5 | 13 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- regulation of transcription by RNA polymerase II
- multicellular organism development
- positive regulation of transcription, DNA-templated
Molecular Function
- DNA-binding transcription factor activity, RNA polymerase II-specific
- DNA binding
- metal ion binding
Cellular Component
- nucleoplasm
- cytosol
- intracellular membrane-bounded organelle
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000377022
- Coding exons
- 18
- Length
- 160047
- Individuals with no LoFs
- 125740
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 5
- Defined
- 125745
- p
- 0.0000199
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 2.61 | 866 | 1.11e+3 | 0.780 | 0.0000782 | 11414 |
| Missense (PolyPhen) | 387 | 576.91 | 0.67082 | 5772 | ||
| Synonymous | 0.499 | 508 | 523 | 0.972 | 0.0000438 | 3571 |
| Loss of Function | 6.72 | 4 | 60.3 | 0.0663 | 0.00000293 | 718 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.000062 | 0.000062 | rare |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.000027 | 0.000026 | rare |
| South Asian | 0.000033 | 0.000033 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Transcriptional activator (PubMed:23639441, PubMed:27693370). Involved in vascular assembly and morphogenesis through direct transcriptional regulation of EGFL7 (PubMed:23639441). {ECO:0000269|PubMed:23639441, ECO:0000269|PubMed:27693370}.;
Recessive Scores
- pRec
- 0.275
Intolerance Scores
- LoFtool
- 0.00200
- RVIS EVS
- -2.42
- RVIS percentile EVS
- 1.06
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.532
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |